vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and Vital Farms, Inc. (VITL). Click either name above to swap in a different company.
Vital Farms, Inc. is the larger business by last-quarter revenue ($213.6M vs $123.8M, roughly 1.7× NATURES SUNSHINE PRODUCTS INC). Vital Farms, Inc. runs the higher net margin — 7.6% vs 3.3%, a 4.3% gap on every dollar of revenue. On growth, Vital Farms, Inc. posted the faster year-over-year revenue change (28.7% vs 4.7%). NATURES SUNSHINE PRODUCTS INC produced more free cash flow last quarter ($7.6M vs $-32.1M). Over the past eight quarters, Vital Farms, Inc.'s revenue compounded faster (20.2% CAGR vs 5.6%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
Vital Tomosi Dairy Limited is a dairy processing company in Uganda. The company is a joint venture between Vital Capital Fund, "an impact investing fund primarily focused on Sub-Saharan Africa", and "Tomosi Dairy Farms, a Ugandan producer of dairy products".
NATR vs VITL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $213.6M |
| Net Profit | $4.1M | $16.3M |
| Gross Margin | 72.5% | 35.8% |
| Operating Margin | 4.3% | 10.0% |
| Net Margin | 3.3% | 7.6% |
| Revenue YoY | 4.7% | 28.7% |
| Net Profit YoY | 1379.4% | 54.3% |
| EPS (diluted) | $0.23 | $0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $213.6M | ||
| Q3 25 | $128.3M | $198.9M | ||
| Q2 25 | $114.8M | $184.8M | ||
| Q1 25 | $113.2M | $162.2M | ||
| Q4 24 | $118.2M | $166.0M | ||
| Q3 24 | $114.6M | $145.0M | ||
| Q2 24 | $110.6M | $147.4M | ||
| Q1 24 | $111.0M | $147.9M |
| Q4 25 | $4.1M | $16.3M | ||
| Q3 25 | $5.3M | $16.4M | ||
| Q2 25 | $5.3M | $16.6M | ||
| Q1 25 | $4.7M | $16.9M | ||
| Q4 24 | $-321.0K | $10.6M | ||
| Q3 24 | $4.3M | $7.4M | ||
| Q2 24 | $1.3M | $16.3M | ||
| Q1 24 | $2.3M | $19.0M |
| Q4 25 | 72.5% | 35.8% | ||
| Q3 25 | 73.3% | 37.7% | ||
| Q2 25 | 71.7% | 38.9% | ||
| Q1 25 | 72.1% | 38.5% | ||
| Q4 24 | 72.0% | 36.1% | ||
| Q3 24 | 71.3% | 36.9% | ||
| Q2 24 | 71.4% | 39.1% | ||
| Q1 24 | 71.2% | 39.8% |
| Q4 25 | 4.3% | 10.0% | ||
| Q3 25 | 7.0% | 10.8% | ||
| Q2 25 | 3.7% | 12.9% | ||
| Q1 25 | 5.4% | 13.4% | ||
| Q4 24 | 3.8% | 7.8% | ||
| Q3 24 | 4.6% | 6.4% | ||
| Q2 24 | 5.1% | 11.6% | ||
| Q1 24 | 4.2% | 16.3% |
| Q4 25 | 3.3% | 7.6% | ||
| Q3 25 | 4.2% | 8.3% | ||
| Q2 25 | 4.6% | 9.0% | ||
| Q1 25 | 4.2% | 10.4% | ||
| Q4 24 | -0.3% | 6.4% | ||
| Q3 24 | 3.8% | 5.1% | ||
| Q2 24 | 1.2% | 11.1% | ||
| Q1 24 | 2.1% | 12.9% |
| Q4 25 | $0.23 | $0.35 | ||
| Q3 25 | $0.30 | $0.36 | ||
| Q2 25 | $0.28 | $0.36 | ||
| Q1 25 | $0.25 | $0.37 | ||
| Q4 24 | $-0.02 | $0.23 | ||
| Q3 24 | $0.23 | $0.16 | ||
| Q2 24 | $0.07 | $0.36 | ||
| Q1 24 | $0.12 | $0.43 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $48.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $161.6M | $351.3M |
| Total Assets | $261.1M | $518.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | $48.8M | ||
| Q3 25 | $95.6M | $93.8M | ||
| Q2 25 | $81.3M | $108.2M | ||
| Q1 25 | $86.5M | $156.3M | ||
| Q4 24 | $84.7M | $150.6M | ||
| Q3 24 | $78.7M | $149.5M | ||
| Q2 24 | $68.7M | $133.2M | ||
| Q1 24 | $77.8M | $113.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.1M | — |
| Q4 25 | $161.6M | $351.3M | ||
| Q3 25 | $166.7M | $331.2M | ||
| Q2 25 | $163.7M | $309.8M | ||
| Q1 25 | $167.1M | $288.9M | ||
| Q4 24 | $161.0M | $269.3M | ||
| Q3 24 | $162.6M | $253.4M | ||
| Q2 24 | $156.4M | $238.4M | ||
| Q1 24 | $159.7M | $213.3M |
| Q4 25 | $261.1M | $518.7M | ||
| Q3 25 | $264.8M | $481.5M | ||
| Q2 25 | $254.9M | $430.8M | ||
| Q1 25 | $252.7M | $376.9M | ||
| Q4 24 | $240.9M | $359.3M | ||
| Q3 24 | $245.3M | $344.7M | ||
| Q2 24 | $235.8M | $320.5M | ||
| Q1 24 | $247.3M | $300.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $5.8M |
| Free Cash FlowOCF − Capex | $7.6M | $-32.1M |
| FCF MarginFCF / Revenue | 6.1% | -15.1% |
| Capex IntensityCapex / Revenue | 1.9% | 17.8% |
| Cash ConversionOCF / Net Profit | 2.41× | 0.35× |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $-48.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $5.8M | ||
| Q3 25 | $18.5M | $23.4M | ||
| Q2 25 | $4.3M | $-761.0K | ||
| Q1 25 | $2.6M | $5.3M | ||
| Q4 24 | $12.2M | $14.8M | ||
| Q3 24 | $9.6M | $10.0M | ||
| Q2 24 | $1.3M | $16.1M | ||
| Q1 24 | $2.2M | $23.9M |
| Q4 25 | $7.6M | $-32.1M | ||
| Q3 25 | $16.8M | $-10.6M | ||
| Q2 25 | $3.0M | $-7.6M | ||
| Q1 25 | $1.5M | $2.1M | ||
| Q4 24 | $10.0M | $-3.4M | ||
| Q3 24 | $7.9M | $6.4M | ||
| Q2 24 | $-2.0M | $10.5M | ||
| Q1 24 | $-1.5M | $22.6M |
| Q4 25 | 6.1% | -15.1% | ||
| Q3 25 | 13.1% | -5.3% | ||
| Q2 25 | 2.6% | -4.1% | ||
| Q1 25 | 1.3% | 1.3% | ||
| Q4 24 | 8.5% | -2.0% | ||
| Q3 24 | 6.9% | 4.4% | ||
| Q2 24 | -1.9% | 7.2% | ||
| Q1 24 | -1.4% | 15.3% |
| Q4 25 | 1.9% | 17.8% | ||
| Q3 25 | 1.3% | 17.1% | ||
| Q2 25 | 1.2% | 3.7% | ||
| Q1 25 | 1.0% | 1.9% | ||
| Q4 24 | 1.9% | 10.9% | ||
| Q3 24 | 1.5% | 2.5% | ||
| Q2 24 | 3.0% | 3.8% | ||
| Q1 24 | 3.3% | 0.9% |
| Q4 25 | 2.41× | 0.35× | ||
| Q3 25 | 3.46× | 1.43× | ||
| Q2 25 | 0.81× | -0.05× | ||
| Q1 25 | 0.55× | 0.31× | ||
| Q4 24 | — | 1.40× | ||
| Q3 24 | 2.21× | 1.34× | ||
| Q2 24 | 0.97× | 0.99× | ||
| Q1 24 | 0.94× | 1.26× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
VITL
| Eggs And Egg Related Products | $205.8M | 96% |
| Butter And Butter Related Products | $7.7M | 4% |
